about
Large-scale mapping of mutations affecting zebrafish development.Molecular and functional interactions between AKT and SOX2 in breast carcinomaZebrafish xenografts as a tool for in vivo studies on human cancer.Prominent Oncogenic Roles of EVI1 in Breast Carcinoma.Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.Endothelial-to-hematopoietic transition: Notch-ing vessels into blood.Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient miceEcotropic viral integration site 1, a novel oncogene in prostate cancer.Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence.EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease.Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.In Vitro Tumorigenic Assay: The Tumor Spheres Assay.Transition of mesenchymal and epithelial cancer cells depends on α1-4 galactosyltransferase-mediated glycosphingolipids.Modeling hematopoietic disorders in zebrafishAbsence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionStress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesisZebrafish Xenografts for the In Vivo Analysis of Healthy and Malignant Human Hematopoietic Cells
P50
Q33268702-1E1D25D4-691A-46C5-B32A-4A6F733DFDDCQ36685442-77DBC286-2447-4E41-8D9B-C34CD2EC2C12Q38035448-8F874544-D64E-4232-BEAA-146DBAF19C98Q38716103-345476FA-5AB6-4B36-913B-1214913A046AQ38756969-23F16240-F5AD-43A2-9D1C-517960E7FFE9Q38789096-0D9838C1-4D15-45CD-9A9B-F9F09040CD66Q38968878-831ED34D-FB20-43FC-BC51-71B9E07B6B82Q39401617-CAA63FE4-8484-4315-BBD1-64F7824B5185Q42727640-9DA4471F-9705-4548-8EAB-FF9EEFA83445Q43486412-14A35800-7375-4DF2-9421-4B489F38F01DQ45332821-3BE2EAE1-50FC-4417-B8FE-88CFB05CFC7DQ47708416-635AD23F-B906-488B-84AF-4CFDC61B4270Q49544650-D3FF6501-A98E-46F9-9371-095111946E0DQ52430981-21BDA2DB-C9AF-434C-8ACA-549292452032Q90099864-D8DE4A99-74BD-4927-AF6C-85D89355E1EFQ91969349-997A1883-0D3B-4227-A250-D2892B3A005DQ92138562-69EAF166-ED9C-4877-A695-193DA0C1A1E7Q92737383-9ED12A4B-5891-4D8F-8475-C80C83E0D4A6
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Martina Konantz
@ast
Martina Konantz
@en
Martina Konantz
@es
Martina Konantz
@nl
type
label
Martina Konantz
@ast
Martina Konantz
@en
Martina Konantz
@es
Martina Konantz
@nl
prefLabel
Martina Konantz
@ast
Martina Konantz
@en
Martina Konantz
@es
Martina Konantz
@nl
P106
P1153
15840045700
P21
P31
P496
0000-0002-4319-3119